Clinical characteristics of pregnant women with COVID-19 in Japan: a nationwide questionnaire survey

Few reports have presented an overall view of pregnant women with coronavirus disease 2019 (COVID-19) across an entire country and throughout the entire gestation period. Furthermore, no such reports are avail...
Source: BMC Pregnancy and Childbirth - Category: OBGYN Authors: Tags: Research Source Type: research

Related Links:

They remain susceptible to the virus for longer after the first vaccination, but achieve a mostly normal response after the second, a study says.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Women and Girls Pregnancy and Childbirth Breastfeeding Vaccination and Immunization Immune System Coronavirus (2019-nCoV) Antibodies Source Type: news
Easy-read guides providing information on coronavirus (COVID-19) and vaccination. 27 October 2021Added links to English large print, Braille and British Sign Language versions of easy-read leaflet on COVID-19 vaccination for women who might get pregnant, who are pregnant or are breastfeeding their baby. 7 October 2021Updated information on COVID-19 vaccination: easy-read guide.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news
Analysis: early uncertainty around vaccination advice for expectant mothers has left them confused and hesitantPregnant women are being turned away from Covid vaccine clinics, experts warnCoronavirus – latest updatesIn the early stages of the coronavirus pandemic, there was uncertainty around almost everything, from who was more adversely affected by Covid-19 to who should get vaccinated first – or at all.But as awareness about the illness and vaccine safety has grown, one group in particular remains confused and torn about the risk of immunisation: expectant mothers.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus Pregnancy Vaccines and immunisation Health Science Women Society England NHS UK news Source Type: news
In conclusion, none of the pregnant women with COVID-19 experienced severe infection or death, unlike non-pregnant women of childbearing age.PMID:34697931 | DOI:10.3346/jkms.2021.36.e290
Source: Journal of Korean Medical Science - Category: Biomedical Science Authors: Source Type: research
J Obstet Gynaecol. 2021 Oct 25:1-3. doi: 10.1080/01443615.2021.1960290. Online ahead of print.ABSTRACTAs coronavirus disease 2019 (COVID-19) sweeps all over the world, Information about COVID-19 is evolving rapidly and interim guidance by multiple organisations is constantly being updated and expanded. Early with discovery of COVID 19, it was reported that pregnancy did affect the progress of the disease severity. Recently, Centres for Disease Control and Prevention (CDC) reported that pregnancy is a risk factors for COVID-19 severity. The current case report is presenting a peripartum COVID-19 positive mortality case.PMID...
Source: Journal of Obstetrics and Gynaecology - Category: OBGYN Authors: Source Type: research
BJOG. 2021 Oct 23. doi: 10.1111/1471-0528.16981. Online ahead of print.ABSTRACTUnlike many viral infections such as influenza, and the two previous incarnations of the coronavirus, SARS and MERS, Covid-19 originally appeared to be of similar severity, after adjusting for age, BMI and other co-morbidities, in the pregnant as in the non-pregnant population. Worryingly the paper from the Italian Obstetric Surveillance System COVID-19 Working Group (p …), suggests that, in pregnancy, the virus may be getting more virulent with the advent of newer variants. Specifically the need for ventilation or ICU admission was signi...
Source: BJOG : An International Journal of Obstetrics and Gynaecology - Category: OBGYN Authors: Source Type: research
NEW BRUNSWICK, N.J., October 21, 2021 – Johnson &Johnson (the Company) today announced that the U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP), has recommended its COVID-19 vaccine as a booster for all eligible individuals who receive an authorized COVID-19 vaccine. “Today’s recommendation supports the use of the Johnson &Johnson COVID-19 vaccine as a booster for eligible individuals in the U.S. regardless of which vaccine they initially receive,” said Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific...
Source: Johnson and Johnson - Category: Pharmaceuticals Source Type: news
CONCLUSIONS: Our study, which is the largest prospective consecutive cohort to date, has confirmed that advanced maternal age, diabetes, hypertension, obesity, very high social vulnerability, and low socioeconomic status are risk factors of COVID-19-related mortality This article is protected by copyright. All rights reserved.PMID:34672382 | DOI:10.1002/uog.24797
Source: The Ultrasound Review of Obstetrics and Gynecology - Category: Radiology Authors: Source Type: research
NEW BRUNSWICK, N.J., October 20, 2021 – Johnson &Johnson (NYSE: JNJ) (the Company) today announced the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for a booster dose of the Johnson &Johnson COVID-19 vaccine for adults aged 18 and older at least two months following primary vaccination with single-shot Johnson &Johnson COVID-19 vaccine; and for eligible individuals who received a different authorized or approved COVID-19 vaccine. The Johnson &Johnson booster shot will be the same formulation and dosage as the primary shot. The EUA follows a unanimous recommendat...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Latest News Source Type: news
Neuropharmacology. 2021 Oct 16;201:108841. doi: 10.1016/j.neuropharm.2021.108841. Online ahead of print.ABSTRACTA strong association between perinatal viral infections and neurodevelopmental disorders has been established. Both the direct contact of the virus with the developing brain and the strong maternal immune response originated by viral infections can impair proper neurodevelopment. Coronavirus disease 2019 (COVID-19), caused by the highly-infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is currently responsible for a large global outbreak and is a major public health issue. While initial stu...
Source: Neuropharmacology - Category: Drugs & Pharmacology Authors: Source Type: research
More News: Coronavirus | COVID-19 | Japan Health | OBGYN | Pregnancy | Women